Metabolic State Determines Central and Peripheral Mechanisms of Liraglutide-Enhanced Insulin Secretion
Caroline Bonner(Inserm), Vincent Prévot(Inserm), François Pattou(Inserm), Markus Schwaninger(University of Lübeck), Markus Mühlemann(Inserm), Chiara Saponaro(University of Pisa), Rubén Nogueiras(Universidade de Santiago de Compostela), Ana Acosta-Montalvo(Inserm), Begoña Porteiro(Universidade de Santiago de Compostela), Shiqian Chen(Imperial College London), Eve Wemelle(Inserm), Frank W. Pfrieger(Institut des Neurosciences Cellulaires et Intégratives), Nathalie Delalleau(Inserm), Mónica Imbernón(Universidade de Santiago de Compostela), Ben Jones(Hammersmith Hospital), Julien Thévenet(Inserm), Eleonora Deligia(Inserm), Isaline Louvet(Inserm), Claude Knauf(Université Toulouse III - Paul Sabatier), Iona Davies(Imperial College London), Gianni Pasquetti(Inserm), Lorea Zubiaga(Inserm), Julie Kerr‐Conte(Inserm), F. Auger(Direction des Energies), Patrik Rorsman(University of Oxford), Maria Moreno‐Lopez(Inserm), Bart Staels(Inserm), Laskshmi Kothagali(University of Gothenburg), Valéry Gmyr(Inserm)
Cited by 0
Related Papers
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
|Journal of Hepatology|2014|1.5k
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
|Journal of Biological Chemistry|1999|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901